Philip T Sager Selected Research

Philip T Sager Research Topics

4	Type 2 Diabetes Mellitus (MODY) 02/2016 - 10/2007
3	Ventricular Tachycardia 11/2022 - 03/2003
3	Stroke (Strokes) 01/2019 - 02/2016
3	Torsades de Pointes (Torsade de Pointes) 08/2018 - 03/2014
3	Hypercholesterolemia 02/2005 - 05/2003
2	Hemorrhage 01/2018 - 06/2015
2	Neoplasms (Cancer) 01/2018 - 08/2015
2	Coronary Disease (Coronary Heart Disease) 10/2007 - 04/2005
1	Seizures (Absence Seizure) 01/2022
1	Short Qt Syndrome 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2021
1	Myocardial Infarction 01/2019
1	Cardiac Arrhythmias (Arrythmia) 08/2018
1	Hemorrhagic Stroke 01/2018
1	Atrial Fibrillation 01/2018
1	Supraventricular Tachycardia 01/2018
1	Heart Failure 02/2016
1	Unstable Angina 02/2016
1	Cardiotoxicity 01/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2015
1	Heart Diseases (Heart Disease) 06/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2015
1	Hypertension (High Blood Pressure) 06/2006
1	Proteinuria 06/2006
1	Atherosclerosis 02/2005
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2005

4	Ezetimibe (Zetia)FDA Link 04/2005 - 05/2003
3	Pharmaceutical PreparationsIBA 08/2018 - 01/2016
3	C-Reactive ProteinIBA 10/2007 - 12/2003
3	Simvastatin (Zocor)FDA LinkGeneric 04/2005 - 12/2003
2	etripamilIBA 11/2022 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2019 - 02/2016
2	dulaglutideIBA 02/2016 - 10/2014
2	Ion Channels (Ion Channel)IBA 01/2016 - 06/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015 - 10/2014
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2007 - 06/2006
2	Atorvastatin (Lipitor)FDA Link 10/2007 - 05/2003
1	CenobamateIBA 01/2022
1	PerhexilineIBA 12/2021
1	ulixertinibIBA 01/2018
1	N(4)-oleylcytosine arabinosideIBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Nasal SpraysIBA 01/2018
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	SodiumIBA 01/2016
1	CalciumIBA 01/2016
1	romidepsin (FK228)FDA Link 08/2015
1	Histone Deacetylase InhibitorsIBA 08/2015
1	AnticoagulantsIBA 06/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2014
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2014
1	SilverIBA 03/2014
1	LDL CholesterolIBA 10/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2007
1	oxidized low density lipoproteinIBA 04/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2005
1	CholesterolIBA 02/2005
1	Coenzyme A (CoA)IBA 02/2005
1	Oxidoreductases (Dehydrogenase)IBA 02/2005
1	Histamine Antagonists (Antihistamines)IBA 03/2003

2	Therapeutics 08/2015 - 01/2015
1	Contraindications 01/2018